patientid,drugname,drugcategory,administratedate,line_of_therapy,regimen,line_start_date,line_end_date,regimen_status
1,5-fluorouracil,chemotherapy,2023-01-05,1,5-fluorouracil,2023-01-05 00:00:00,2023-01-05 00:00:00,Initial Drug
1,leucovorin,chemotherapy,2023-01-05,1,5-fluorouracil+leucovorin,2023-01-05 00:00:00,2023-01-05 00:00:00,Initial Combination
1,oxaliplatin,chemotherapy,2023-01-05,1,5-fluorouracil+leucovorin+oxaliplatin,2023-01-05 00:00:00,2023-01-05 00:00:00,Initial Combination
1,5-fluorouracil,chemotherapy,2023-01-19,1,5-fluorouracil+leucovorin+oxaliplatin,2023-01-05 00:00:00,2023-01-19 00:00:00,Continuation
1,leucovorin,chemotherapy,2023-01-19,1,5-fluorouracil+leucovorin+oxaliplatin,2023-01-05 00:00:00,2023-01-19 00:00:00,Continuation
1,oxaliplatin,chemotherapy,2023-01-19,1,5-fluorouracil+leucovorin+oxaliplatin,2023-01-05 00:00:00,2023-01-19 00:00:00,Continuation
1,bevacizumab,biologics,2023-02-10,1,5-fluorouracil+bevacizumab+leucovorin+oxaliplatin,2023-01-05 00:00:00,2023-02-10 00:00:00,Biologic Addition (Within Window)
1,5-fluorouracil,chemotherapy,2023-02-10,1,5-fluorouracil+bevacizumab+leucovorin+oxaliplatin,2023-01-05 00:00:00,2023-02-10 00:00:00,Continuation
1,leucovorin,chemotherapy,2023-02-10,1,5-fluorouracil+bevacizumab+leucovorin+oxaliplatin,2023-01-05 00:00:00,2023-02-10 00:00:00,Continuation
1,oxaliplatin,chemotherapy,2023-02-10,1,5-fluorouracil+bevacizumab+leucovorin+oxaliplatin,2023-01-05 00:00:00,2023-02-10 00:00:00,Continuation
1,cetuximab,targeted,2023-05-15,2,cetuximab,2023-05-15 00:00:00,2023-05-15 00:00:00,New Line (EGFR Addition/Switch)
1,irinotecan,chemotherapy,2023-05-15,2,cetuximab+irinotecan,2023-05-15 00:00:00,2023-05-15 00:00:00,Initial Combination
1,5-fluorouracil,chemotherapy,2023-05-15,2,5-fluorouracil+cetuximab+irinotecan,2023-05-15 00:00:00,2023-05-15 00:00:00,Initial Combination
1,leucovorin,chemotherapy,2023-05-15,2,5-fluorouracil+cetuximab+irinotecan+leucovorin,2023-05-15 00:00:00,2023-05-15 00:00:00,Initial Combination
1,cetuximab,targeted,2023-05-29,2,5-fluorouracil+cetuximab+irinotecan+leucovorin,2023-05-15 00:00:00,2023-05-29 00:00:00,Continuation
1,irinotecan,chemotherapy,2023-05-29,2,5-fluorouracil+cetuximab+irinotecan+leucovorin,2023-05-15 00:00:00,2023-05-29 00:00:00,Continuation
1,5-fluorouracil,chemotherapy,2023-05-29,2,5-fluorouracil+cetuximab+irinotecan+leucovorin,2023-05-15 00:00:00,2023-05-29 00:00:00,Continuation
1,leucovorin,chemotherapy,2023-05-29,2,5-fluorouracil+cetuximab+irinotecan+leucovorin,2023-05-15 00:00:00,2023-05-29 00:00:00,Continuation
1,panitumumab,targeted,2023-09-20,3,panitumumab,2023-09-20 00:00:00,2023-09-20 00:00:00,New Line (EGFR Addition/Switch)
1,capecitabine,chemotherapy,2023-09-20,3,capecitabine+panitumumab,2023-09-20 00:00:00,2023-09-20 00:00:00,Initial Combination
2,capecitabine,chemotherapy,2023-02-01,1,capecitabine,2023-02-01 00:00:00,2023-02-01 00:00:00,Initial Drug
2,capecitabine,chemotherapy,2023-02-22,1,capecitabine,2023-02-01 00:00:00,2023-02-22 00:00:00,Continuation
2,oxaliplatin,chemotherapy,2023-03-15,1,capecitabine+oxaliplatin,2023-02-01 00:00:00,2023-03-15 00:00:00,Chemo Addition (Within Window)
2,capecitabine,chemotherapy,2023-03-15,1,capecitabine+oxaliplatin,2023-02-01 00:00:00,2023-03-15 00:00:00,Continuation
2,capecitabine,chemotherapy,2023-04-05,1,capecitabine+oxaliplatin,2023-02-01 00:00:00,2023-04-05 00:00:00,Continuation
2,capecitabine,chemotherapy,2023-04-26,1,capecitabine+oxaliplatin,2023-02-01 00:00:00,2023-04-26 00:00:00,Continuation
2,capecitabine,chemotherapy,2023-05-17,1,capecitabine+oxaliplatin,2023-02-01 00:00:00,2023-05-17 00:00:00,Continuation
2,capecitabine,chemotherapy,2023-06-07,1,capecitabine+oxaliplatin,2023-02-01 00:00:00,2023-06-07 00:00:00,Continuation
2,capecitabine,chemotherapy,2023-06-28,1,capecitabine+oxaliplatin,2023-02-01 00:00:00,2023-06-28 00:00:00,Continuation
2,capecitabine,chemotherapy,2023-07-19,1,capecitabine+oxaliplatin,2023-02-01 00:00:00,2023-07-19 00:00:00,Continuation
2,capecitabine,chemotherapy,2023-08-09,1,capecitabine+oxaliplatin,2023-02-01 00:00:00,2023-08-09 00:00:00,Continuation
2,capecitabine,chemotherapy,2023-08-30,1,capecitabine+oxaliplatin,2023-02-01 00:00:00,2023-08-30 00:00:00,Continuation
2,capecitabine,chemotherapy,2023-09-20,1,capecitabine+oxaliplatin,2023-02-01 00:00:00,2023-09-20 00:00:00,Continuation
2,capecitabine,chemotherapy,2023-10-11,1,capecitabine+oxaliplatin,2023-02-01 00:00:00,2023-10-11 00:00:00,Continuation
2,capecitabine,chemotherapy,2023-11-01,1,capecitabine+oxaliplatin,2023-02-01 00:00:00,2023-11-01 00:00:00,Continuation
2,capecitabine,chemotherapy,2023-11-22,1,capecitabine+oxaliplatin,2023-02-01 00:00:00,2023-11-22 00:00:00,Continuation
2,capecitabine,chemotherapy,2023-12-13,1,capecitabine+oxaliplatin,2023-02-01 00:00:00,2023-12-13 00:00:00,Continuation
3,5-fluorouracil,chemotherapy,2023-03-01,1,5-fluorouracil,2023-03-01 00:00:00,2023-03-01 00:00:00,Initial Drug
3,leucovorin,chemotherapy,2023-03-01,1,5-fluorouracil+leucovorin,2023-03-01 00:00:00,2023-03-01 00:00:00,Initial Combination
3,cetuximab,targeted,2023-03-01,1,5-fluorouracil+cetuximab+leucovorin,2023-03-01 00:00:00,2023-03-01 00:00:00,Initial Combination
3,5-fluorouracil,chemotherapy,2023-03-15,1,5-fluorouracil+cetuximab+leucovorin,2023-03-01 00:00:00,2023-03-15 00:00:00,Continuation
3,leucovorin,chemotherapy,2023-03-15,1,5-fluorouracil+cetuximab+leucovorin,2023-03-01 00:00:00,2023-03-15 00:00:00,Continuation
3,cetuximab,targeted,2023-03-15,1,5-fluorouracil+cetuximab+leucovorin,2023-03-01 00:00:00,2023-03-15 00:00:00,Continuation
3,cetuximab,targeted,2023-04-20,1,5-fluorouracil+cetuximab+leucovorin,2023-03-01 00:00:00,2023-04-20 00:00:00,Continuation
3,5-fluorouracil,chemotherapy,2023-07-01,1,5-fluorouracil+cetuximab+leucovorin,2023-03-01 00:00:00,2023-07-01 00:00:00,Continuation
3,leucovorin,chemotherapy,2023-07-01,2,leucovorin,2023-07-01 00:00:00,2023-07-01 00:00:00,New Line (Chemo Addition to FLU)
3,cetuximab,targeted,2023-07-01,2,cetuximab+leucovorin,2023-07-01 00:00:00,2023-07-01 00:00:00,Initial Combination
4,capecitabine,chemotherapy,2023-04-10,1,capecitabine,2023-04-10 00:00:00,2023-04-10 00:00:00,Initial Drug
4,cetuximab,targeted,2023-07-15,2,cetuximab,2023-07-15 00:00:00,2023-07-15 00:00:00,New Line (EGFR Addition/Switch)
5,5-fluorouracil,chemotherapy,2023-05-01,1,5-fluorouracil,2023-05-01 00:00:00,2023-05-01 00:00:00,Initial Drug
5,cetuximab,targeted,2023-08-01,2,cetuximab,2023-08-01 00:00:00,2023-08-01 00:00:00,New Line (EGFR Addition/Switch)
5,panitumumab,targeted,2023-08-15,2,cetuximab+panitumumab,2023-08-01 00:00:00,2023-08-15 00:00:00,Initial Combination
5,cetuximab,targeted,2023-09-01,2,cetuximab+panitumumab,2023-08-01 00:00:00,2023-09-01 00:00:00,Continuation
